The secret to a successful cataract surgery in diabetics lies in making informed decisions. Instead of being influenced by ...

A study, published in Science Translational Medicine, revealed that diabetic mice in induced periods of low sugar were ...

Thanks to advancements in early detection and treatment options, it's possible to live a long and healthy life after being ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at least 2 intravitreal ...

According to the Ministry of Health and Welfare's National Health and Nutrition Survey, the prevalence of diabetes in 2023 ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Fear is a natural response when something threatens your vision—but it’s also a signal to act quickly. Some retinal ...

Telangiectatic capillaries may have potential clinical relevance for diagnosis and treatment of diabetic macular edema.

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ranibizumab, is delivered through an ocular implant that is refilled every nine ...

Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...